The designation Swi1 Activators would pertain to a class of chemicals that target and enhance the function of the Swi1 protein, which is known to play a role in the regulation of chromatin structure and gene expression. Swi1 is part of the SWI/SNF (switch/sucrose non-fermentable) complex, a chromatin remodeling complex that is evolutionarily conserved from yeast to humans. In the context of gene regulation, Swi1 is involved in the ATP-dependent remodeling of chromatin, which makes the DNA more or less accessible to transcription factors and other proteins that control gene expression. Activators of Swi1 would therefore be expected to enhance the remodeling activity of the SWI/SNF complex, potentially by increasing the ATPase activity of the complex, by stabilizing the complex on chromatin, or by promoting the interaction of Swi1 with other subunits or regulatory factors that modulate its function.
Understanding the biochemical and molecular mechanisms by which Swi1 activators exert their effects would involve a multi-faceted approach. On a biochemical level, assays to measure ATPase activity could reveal how Swi1 activators influence the energy-dependent remodeling of chromatin. Additionally, binding studies using purified Swi1 protein and potential activators could delineate the interaction dynamics, such as the affinity of the activators for Swi1 and any conformational changes induced by activator binding. On a molecular level, the impact of Swi1 activators could be assessed by evaluating changes in the expression of genes known to be regulated by the SWI/SNF complex. Techniques such as chromatin immunoprecipitation (ChIP) followed by sequencing could be employed to identify regions of chromatin where Swi1 is actively recruiting the SWI/SNF complex in the presence of these activators, providing a genome-wide view of how Swi1 activation affects chromatin architecture and gene expression patterns. Through these methods, the role of Swi1 activators in modulating chromatin structure and its subsequent effects on gene regulation could be elucidated.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
A histone deacetylase inhibitor that may promote chromatin relaxation and increase expression of genes like Swi1. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
It is another histone deacetylase inhibitor that could potentially enhance the transcription of chromatin remodeling factors. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that may lead to hypomethylation of the Swi1 gene promoter, increasing its expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Similar to azacitidine, decitabine could induce hypomethylation and upregulation of genes involved in chromatin remodeling. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
A non-nucleoside DNA methyltransferase inhibitor that might result in the upregulation of Swi1 by altering methylation patterns. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
This selective HDAC inhibitor may lead to a more accessible chromatin state, potentially increasing Swi1 expression. | ||||||
Sirtinol | 410536-97-9 | sc-205976 sc-205976A | 1 mg 5 mg | $38.00 $113.00 | 14 | |
An inhibitor of sirtuin HDACs, which might indirectly lead to changes in the expression of genes like Swi1. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A potent HDAC inhibitor that can cause changes in chromatin structure, potentially increasing the expression of Swi1. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
A short-chain fatty acid and HDAC inhibitor that could induce hyperacetylation of histones and upregulation of Swi1. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
It is an HDAC inhibitor that may affect gene expression patterns, possibly including Swi1. | ||||||